Submitted by Anonymous (not verified) on 10 November 2023 - 12:17 Summary of opinion: Rimmyrah,ranibizumab, 09/11/2023, Positive Link: https://www.ema.europa.eu/en/medicines/human/summaries-opinion/rimmyrahSource: What's new